<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Epidemiology</title>
<title_fa>مجله اپیدمیولوژی ایران</title_fa>
<short_title>irje</short_title>
<subject>Medical Sciences</subject>
<web_url>http://irje.tums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1735-7489</journal_id_issn>
<journal_id_issn_online>2228-7507</journal_id_issn_online>
<journal_id_pii>000</journal_id_pii>
<journal_id_doi>000</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>000</journal_id_sid>
<journal_id_nlai>000</journal_id_nlai>
<journal_id_science>000</journal_id_science>
<language>fa</language>
<pubdate>
	<type>jalali</type>
	<year>1394</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa>تناقض چاقی: رخداد بیماری عروق کرونر قلب در مبتلایان به بیماری مزمن کلیوی و سندرم متابولیک</title_fa>
	<title>Obesity Paradox: Incidence of Coronary Heart Disease in Patients with Chronic Kidney Disease and Metabolic Syndrome </title>
	<subject_fa>عمومى</subject_fa>
	<subject>General</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa>&lt;div style=&quot;BORDER-BOTTOM: windowtext 1pt solid BORDER-LEFT: medium none PADDING-BOTTOM: 1pt PADDING-LEFT: 0cm PADDING-RIGHT: 0cm MARGIN-LEFT: 0cm BORDER-TOP: windowtext 1pt solid MARGIN-RIGHT: 87.6pt BORDER-RIGHT: medium none PADDING-TOP: 1pt mso-element: para-border-div mso-border-top-alt: solid windowtext .5pt mso-border-bottom-alt: solid windowtext .5pt&quot;&gt;
&lt;p class=&quot;IJE-F-Abstract&quot; dir=&quot;rtl&quot; style=&quot;BORDER-BOTTOM: medium none BORDER-LEFT: medium none PADDING-BOTTOM: 0cm MARGIN: 0cm 0cm 0pt PADDING-LEFT: 0cm PADDING-RIGHT: 0cm BORDER-TOP: medium none BORDER-RIGHT: medium none PADDING-TOP: 0cm mso-border-top-alt: solid windowtext .5pt mso-border-bottom-alt: solid windowtext .5pt mso-hyphenate: auto mso-padding-alt: 1.0pt 0cm 1.0pt 0cm&quot;&gt;&lt;b&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-font-size:=&quot;&quot; mso-bidi-language:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;مقدمه و اهداف:&lt;/span&gt;&lt;/b&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-font-size:=&quot;&quot; mso-bidi-language:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;مطالعه‌های بیماری‌های مزمن نشان می‌دهند که ممکن است افراد چاق به طور متناقضی، بقای بهتری داشته باشند. هدف از این مطالعه، ارزیابی اثر بیماری مزمن کلیوی و سندرم متابولیک در رخداد بیماری عروق کرونر قلب &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;می‌باشد&lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-font-size:=&quot;&quot; mso-bidi-language:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p class=&quot;IJE-F-Abstract&quot; dir=&quot;rtl&quot; style=&quot;BORDER-BOTTOM: medium none BORDER-LEFT: medium none PADDING-BOTTOM: 0cm MARGIN: 0cm 0cm 0pt PADDING-LEFT: 0cm PADDING-RIGHT: 0cm BORDER-TOP: medium none BORDER-RIGHT: medium none PADDING-TOP: 0cm mso-border-top-alt: solid windowtext .5pt mso-border-bottom-alt: solid windowtext .5pt mso-hyphenate: auto mso-padding-alt: 1.0pt 0cm 1.0pt 0cm&quot;&gt;&lt;b&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-font-size:=&quot;&quot; mso-bidi-language:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;روش کار:&lt;/span&gt;&lt;/b&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-font-size:=&quot;&quot; mso-bidi-language:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; به &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;منظور بررسی رخداد بیماری عروق کرونر قلب 6507&lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; نفر شرکت کننده (میانگین سنی 4/47 سال، 4/43 درصد مرد) به &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;مدت 10 سال&lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;پیگیری &lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;شدند.&lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; شرکت‌کننده‌ها بر اساس وجود یا عدم وجود &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; style=&quot;FONT-FAMILY: &quot;&gt;بیماری مزمن کلیوی و سندرم متابولیک&lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; به 4 گروه تقسیم شدند. سپس با استفاده از مدل رگرسیونی چند متغیره کاکس نسبت مخاطره گروه‌ها نسبت به گروه بدون بیماری مزمن کلیوی و سندرم متابولیک در &lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;1/27&lt;/span&gt;&lt;span color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; new=&quot;&quot; style=&quot;FONT-FAMILY: &quot; times=&quot;&quot;&gt;&gt;&lt;/span&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;span dir=&quot;ltr&quot; lang=&quot;X-NONE&quot; style=&quot;mso-bidi-font-family: &#039;B Nazanin&#039;&quot;&gt;BMI&lt;/span&gt;&lt;/font&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;X-NONE&quot; mso-ansi-font-size:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;و&lt;span style=&quot;COLOR: black&quot;&gt;&lt;font face=&quot;B Nazanin&quot; size=&quot;2&quot;&gt; &lt;/font&gt;&lt;/span&gt;&lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;1/27&lt;/span&gt;&lt;span color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; sakkal=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;&amp;le&lt;/span&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;span dir=&quot;ltr&quot; lang=&quot;X-NONE&quot; style=&quot;mso-bidi-font-family: &#039;B Nazanin&#039;&quot;&gt;BMI&lt;/span&gt;&lt;/font&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; new=&quot;&quot; style=&quot;FONT-FAMILY: &quot; times=&quot;&quot;&gt; محاسبه&lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; شد&lt;/span&gt;&lt;span b=&quot;&quot; dir=&quot;ltr&quot; lang=&quot;X-NONE&quot; mso-bidi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p class=&quot;IJE-F-Abstract&quot; dir=&quot;rtl&quot; style=&quot;BORDER-BOTTOM: medium none BORDER-LEFT: medium none PADDING-BOTTOM: 0cm MARGIN: 0cm 0cm 0pt PADDING-LEFT: 0cm PADDING-RIGHT: 0cm BORDER-TOP: medium none BORDER-RIGHT: medium none PADDING-TOP: 0cm mso-border-top-alt: solid windowtext .5pt mso-border-bottom-alt: solid windowtext .5pt mso-hyphenate: auto mso-padding-alt: 1.0pt 0cm 1.0pt 0cm&quot;&gt;&lt;b&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-font-size:=&quot;&quot; mso-bidi-language:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;نتایج:&lt;/span&gt;&lt;/b&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-font-size:=&quot;&quot; mso-bidi-language:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; &lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;&lt;span style=&quot;mso-spacerun: yes&quot;&gt;&lt;font face=&quot;B Nazanin&quot; size=&quot;2&quot;&gt; &lt;/font&gt;&lt;/span&gt;&lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;نسبت مخاطره&lt;b&gt; &lt;/b&gt;&lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;در مردان و زنان &lt;/span&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;span dir=&quot;ltr&quot; lang=&quot;X-NONE&quot; style=&quot;mso-bidi-font-family: &#039;B Nazanin&#039;&quot;&gt;BMI&lt;/span&gt;&lt;/font&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; پائین با بیماری مزمن کلیوی و بدون سندرم متابولیک به ترتیب &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;06/2 (فاصله اطمینان 95 درصد: 31/3-28/1) و &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;56/2 (&lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;فاصله اطمینان 95 درصد: &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;31/6-04/1) بود. این مقدار در بیماران &lt;/span&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;span dir=&quot;ltr&quot; lang=&quot;X-NONE&quot; style=&quot;mso-bidi-font-family: &#039;B Nazanin&#039;&quot;&gt;BMI&lt;/span&gt;&lt;/font&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; new=&quot;&quot; style=&quot;FONT-FAMILY: &quot; times=&quot;&quot;&gt; بالا از نظر آماری معنی‌دار نبود. هم‌چنین در مردان و زنان &lt;/span&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;span dir=&quot;ltr&quot; lang=&quot;X-NONE&quot; style=&quot;mso-bidi-font-family: &#039;B Nazanin&#039;&quot;&gt;BMI&lt;/span&gt;&lt;/font&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; پائین &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; new=&quot;&quot; style=&quot;FONT-FAMILY: &quot; times=&quot;&quot;&gt;مبتلا به سندرم متابولیک بدون بیماری مزمن کلیوی، &lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;نسبت مخاطره به ترتیب&lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;52/2 (فاصله اطمینان 95 درصد: 73/3-71/1) و &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;68/4 (&lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;فاصله اطمینان 95 درصد: &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;95/9-20/2) بود. در بیماران&lt;/span&gt;&lt;span b=&quot;&quot; dir=&quot;ltr&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-bidi-font-family:=&quot;&quot; new=&quot;&quot; style=&quot;FONT-FAMILY: &quot; times=&quot;&quot;&gt; &lt;/span&gt;&lt;span dir=&quot;ltr&quot; lang=&quot;X-NONE&quot; style=&quot;mso-bidi-font-family: &#039;B Nazanin&#039;&quot;&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;BMI&lt;/font&gt;&lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; new=&quot;&quot; style=&quot;FONT-FAMILY: &quot; times=&quot;&quot;&gt;بالا این مقادیر &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;70/1 (فاصله اطمینان 95 درصد: 78/2-05/1) و &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;90/1 (&lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;فاصله اطمینان 95 درصد: &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;13/3-16/1) بود.&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p class=&quot;IJE-F-Abstract&quot; dir=&quot;rtl&quot; style=&quot;BORDER-BOTTOM: medium none BORDER-LEFT: medium none PADDING-BOTTOM: 0cm MARGIN: 0cm 0cm 0pt PADDING-LEFT: 0cm PADDING-RIGHT: 0cm BORDER-TOP: medium none BORDER-RIGHT: medium none PADDING-TOP: 0cm mso-border-top-alt: solid windowtext .5pt mso-border-bottom-alt: solid windowtext .5pt mso-hyphenate: auto mso-padding-alt: 1.0pt 0cm 1.0pt 0cm&quot;&gt;&lt;b&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-font-size:=&quot;&quot; mso-bidi-language:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;نتیجه‏گیری:&lt;/span&gt;&lt;/b&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-IQ&quot; mso-ansi-font-size:=&quot;&quot; mso-bidi-language:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;این نتایج نشان می‌دهد که &lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;خطر بروز بیماری عروق کرونر قلب در افراد &lt;/span&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;span dir=&quot;ltr&quot; lang=&quot;X-NONE&quot; style=&quot;mso-bidi-font-family: &#039;B Nazanin&#039;&quot;&gt;BMI&lt;/span&gt;&lt;/font&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;X-NONE&quot; mso-ansi-font-size:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt; &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;پائین &lt;/span&gt;&lt;span b=&quot;&quot; color:=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;مبتلا به سندرم متابولیک و بدون بیماری مزمن کلیوی تقریباً دو برابر &lt;/span&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; style=&quot;FONT-FAMILY: &quot;&gt;بیماران &lt;/span&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;span dir=&quot;ltr&quot; lang=&quot;X-NONE&quot; style=&quot;mso-bidi-font-family: &#039;B Nazanin&#039;&quot;&gt;BMI&lt;/span&gt;&lt;/font&gt;&lt;span b=&quot;&quot; font-size:=&quot;&quot; lang=&quot;AR-SA&quot; mso-ansi-language:=&quot;&quot; mso-ascii-font-family:=&quot;&quot; mso-hansi-font-family:=&quot;&quot; new=&quot;&quot; style=&quot;FONT-FAMILY: &quot; times=&quot;&quot;&gt; بالا می‌باشد.&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;
&lt;/div&gt;
</abstract_fa>
	<abstract>&lt;p class=&quot;IJE-E-Authorsaffiliation&quot; style=&quot;TEXT-ALIGN: justify MARGIN: 0cm 0cm 6pt&quot;&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;b&gt;&lt;span style=&quot;FONT-SIZE: 11pt mso-bidi-font-family: &#039;B Yagut&#039;&quot;&gt;Background &amp; Objectives&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;FONT-SIZE: 11pt mso-bidi-font-family: &#039;B Yagut&#039;&quot;&gt;:&lt;/span&gt;&lt;span style=&quot;FONT-SIZE: 11pt&quot;&gt; &lt;/span&gt;&lt;span style=&quot;FONT-SIZE: 11pt mso-fareast-font-family: &#039;MS Mincho&#039; mso-fareast-language: JA mso-bidi-language: FA&quot;&gt;Some studies on chronic diseases have indicated that obesity may result in a paradoxically longer survival. The present study was aimed to investigate the effect of Chronic Kidney Diseases (CKD) and Metabolic Syndrome (MetS) on the incidence of Coronary Heart Disease (CHD).&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p class=&quot;IJE-L-BodyText&quot; style=&quot;LINE-HEIGHT: normal MARGIN: 0cm 0cm 6pt&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;b&gt;&lt;span style=&quot;mso-fareast-font-family: &#039;Times New Roman&#039; mso-fareast-language: EN-US mso-bidi-language: AR-SA mso-bidi-font-family: &#039;B Yagut&#039; mso-bidi-font-size: 11.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;mso-fareast-font-family: &#039;Times New Roman&#039; mso-fareast-language: EN-US mso-bidi-language: AR-SA mso-bidi-font-family: &#039;B Yagut&#039; mso-bidi-font-size: 11.0pt&quot;&gt; &lt;/span&gt;&lt;span style=&quot;mso-bidi-font-size: 11.0pt&quot;&gt;In order to record time to CHD events, a sample of 6,507 individuals (mean age 47.4 years, 43.4% males) was followed for nearly 10 years. Participants were also categorized into four groups according to presence/absence of CKD and MetS. Then, using a Multivariate Cox Regression, the Hazard Ratio (HR) of each group was estimated relative to individuals free of both CKD and MetS separately for obese (BMI&amp;ge27.1 Kg/m2) and non-obese persons (BMI&lt;27.1 Kg/m2).&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p class=&quot;IJE-L-BodyText&quot; style=&quot;LINE-HEIGHT: normal MARGIN: 0cm 0cm 6pt&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;b&gt;&lt;span style=&quot;mso-bidi-font-family: &#039;B Yagut&#039; mso-bidi-font-size: 11.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;mso-bidi-font-family: &#039;B Yagut&#039; mso-bidi-font-size: 11.0pt&quot;&gt; &lt;/span&gt;&lt;span style=&quot;mso-bidi-font-size: 11.0pt&quot;&gt;HR for non-obese patients with CKD but not MetS was obtained 2.06 (95%CI: 1.28-3.31) in men and 2.56 (1.04-6.31) in women. However, these associations were not significant for obese patients. Furthermore, among non-obese men and women with MetS alone, HR was estimated 2.52 (1.71-3.73) and 4.68 (2.20-9.95), respectively. For obese patients, these values were 1.70 (1.05-2.78) and 1.90 (1.16-3.13), respectively. &lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p class=&quot;IJE-L-BodyText&quot; style=&quot;LINE-HEIGHT: normal MARGIN: 0cm 0cm 6pt&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Tw Cen MT&quot;&gt;&lt;b&gt;&lt;span style=&quot;mso-fareast-font-family: &#039;Times New Roman&#039; mso-fareast-language: EN-US mso-bidi-language: AR-SA mso-bidi-font-family: &#039;B Yagut&#039; mso-bidi-font-size: 11.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;mso-fareast-font-family: &#039;Times New Roman&#039; mso-fareast-language: EN-US mso-bidi-language: AR-SA mso-bidi-font-family: &#039;B Yagut&#039; mso-bidi-font-size: 11.0pt&quot;&gt; &lt;/span&gt;&lt;span style=&quot;mso-bidi-font-size: 11.0pt&quot;&gt;The results reflect that among those who had MetS alone, the risk of CHD incidence was twice higher in non-obese individuals compared to obese patients.&lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;
</abstract>
	<keyword_fa>تناقض چاقی, بیماری عروق کرونر قلب, بیماری مزمن کلیوی, سندرم متابولیک</keyword_fa>
	<keyword>Obesity paradox, Coronary heart disease, Chronic kidney disease, Metabolic syndrome</keyword>
	<start_page>72</start_page>
	<end_page>81</end_page>
	<web_url>http://irje.tums.ac.ir/browse.php?a_code=A-10-25-5108&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>MH</first_name>
	<middle_name></middle_name>
	<last_name>Panahi</last_name>
	<suffix></suffix>
	<first_name_fa>محمد حسین</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>پناهی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa>1گروه اپیدمیولوژی و آمار زیستی، دانشکده بهداشت، دانشگاه علوم پزشکی شهید بهشتی</affiliation_fa>
	 </author>


	<author>
	<first_name>P</first_name>
	<middle_name></middle_name>
	<last_name>Yavari</last_name>
	<suffix></suffix>
	<first_name_fa>پروین</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>یاوری</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>p.yavari-grc@sbmu.ac.ir</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa>گروه بهداشت و پزشکی اجتماعی، دانشکده پزشکی، دانشگاه علوم پزشکی شهید بهشتی</affiliation_fa>
	 </author>


	<author>
	<first_name>D</first_name>
	<middle_name></middle_name>
	<last_name>Khalili</last_name>
	<suffix></suffix>
	<first_name_fa>داود</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>خلیلی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa>گروه اپیدمیولوژی و آمار زیستی، دانشکده بهداشت، دانشگاه علوم پزشکی شهید بهشتی</affiliation_fa>
	 </author>


	<author>
	<first_name>Y</first_name>
	<middle_name></middle_name>
	<last_name>Mehrabi</last_name>
	<suffix></suffix>
	<first_name_fa>یداله</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>محرابی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa>گروه اپیدمیولوژی و آمار زیستی، دانشکده بهداشت، دانشگاه علوم پزشکی شهید بهشتی</affiliation_fa>
	 </author>


	<author>
	<first_name>F</first_name>
	<middle_name></middle_name>
	<last_name>Hadaegh</last_name>
	<suffix></suffix>
	<first_name_fa>فرزاد</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>حدائق</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa>مرکز تحقیقات پیشگیری از بیماری‌های متابولیک، پژ‍وهشکده علوم غدد درون‌ریز، دانشگاه علوم پزشکی شهید بهشتی</affiliation_fa>
	 </author>


	<author>
	<first_name>F</first_name>
	<middle_name></middle_name>
	<last_name>Azizi</last_name>
	<suffix></suffix>
	<first_name_fa>فریدون</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>عزیزی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa>مرکز تحقیقات علوم غدد درون‌ریز و متابولیسم، پژ‍وهشکده علوم غدد درون‌ریز، دانشگاه علوم پزشکی شهید بهشتی</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
